| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |